Jay S Stout sold $26k of IMVT
Chief Technology Officer at Immunovant, Inc.. 1,585 shares at an average of $16.30, traded Oct 8, 2025, filed Oct 10, 2025.
Score components
- +15RoleOfficer
- +5Trade size$26k at market
- 0Share of holdings soldSold 0.8% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +37.1%, 3m +52.8%, 6m +43.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001764013-25-000138, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 8, 2025 | SOpen-market sale Common Stock | -1,585 | $16.30 | $26k | 203,334 | Oct 10, 2025 |
Related signals
Other insiders at Immunovant, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | Immunovant, Inc. | Melanie Gloria Chief Operating Officer | $72k 2,241 shares | -1% | |
| 40Moderate | Immunovant, Inc. | Jay S Stout Chief Technology Officer | $122k 3,809 shares | -2% | |
| 36Weak | Immunovant, Inc. | Christopher Van Tuyl Chief Legal Officer | $43k 1,327 shares | -1% | |
| 35Weak | Immunovant, Inc. | Eric Venker Chief Executive Officer | $120k 3,506 shares | -1% | |
| 40Moderate | Immunovant, Inc. | Christopher Van Tuyl Chief Legal Officer | $103k 2,846 shares | -2% | |
| 38Weak | Immunovant, Inc. | Tiago Girao Chief Financial Officer | $385k 10,000 shares | -4% | |
| 56Moderate | Immunovant, Inc. | Melanie Gloria Chief Operating Officer | $679k 17,714 shares | -7% | |
| 2Weak | Immunovant, Inc. | Atul Pande director | $57k 1,500 shares | -1% | |
| 36Weak | Immunovant, Inc. | Christopher Van Tuyl Chief Legal Officer | $683k 17,824 shares | -9% | |
| 60Notable | Immunovant, Inc. | Jay S Stout Chief Technology Officer | $1.5M 40,000 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.